In the brains of people with AD and transgenic mouse models that overexpress mutated human APP, reactive microglia and astrocytes are observed around Aβ plaques and can have beneficial or harmful roles in disease progression (Dickson et al., 1988; Saito et al., 2014). This evidence concerns the gene APP and Alzheimer disease.